Abstract

Research Article

To compare serum Vitamin D status in pre-eclamptic and non-preeclamptic pregnant women in labour: A tertiary care centre study of Northern India

Monica Karpa, Sita Thakur, Kamal Singh*, Jyoti Sharma and Harsha Chaudhary

Published: 28 January, 2022 | Volume 5 - Issue 1 | Pages: 013-018

Background: Pre-eclampsia and eclampsia have remained a major global public health threat in contributing significantly to maternal and perinatal morbidity and mortality. Based on the inverse relationship between serum 1,25(OH)2D3 levels and plasma renin activity found previously, it is speculated that 1,25(OH)2D3 might be a negative endocrine regulator of renin production in vivo. During pregnancy, vitamin D may play a role in implantation and placental function potentially due to angiogenic, immunomodulatory, and antiinflammatory effects. Vitamin D
deficiency can affect the health of both mother and fetus by increasing the production of inflammatory cytokines and stimulating the activity of T-regulating cells. Vitamin D is emerging as a promising agent for pre-eclampsia prevention. 
Aims and objectives: The objective of this study is to compare the vitamin D levels in pre-eclamptic and healthy non-pre-eclamptic pregnant women in labor and find out the relationship between vitamin D levels and pre-eclampsia. 
Methodology: The present cross-sectional study was carried out on pregnant women with pre-eclampsia in labor. For each case with pre-eclampsia, one uncomplicated, normotensive pregnant woman in labor was taken as control. On admission to the labor room detailed history, physical examination followed by thorough obstetrics and systemic examination was done. Required investigations were done including vitamin D and calcium levels. Maternal and fetal condition was monitored during labor/cesarean section, mode of delivery, maternal and fetal outcomes were recorded. After delivery, 2cc of cord blood was collected in a serum tube and sent for vitamin D levels. Data was collected and analyzed statistically using Epi-info version 7.1.
Results: It was observed that the patients in both groups were comparable with respect to demographic and obstetrics characteristics except for significantly high BP in group I. Vitamin D
deficiency (i.e. < 20 ng/ml) was significantly more in group I as compared to group II and the difference was highly significant (p < 0.0001). Similarly, the mean maternal calcium levels were significantly lower in group I in comparison to group II (p < 0.0001) i.e. the mean maternal calcium level in group I and group II were 8.03 ± 0.94 and 9.19 ± 0.67 respectively. It was also observed that the level of 25-OH-D in neonates of preeclamptic women was significantly lower than for those of the normal pregnant women (p < 0.0001). 
Conclusion: Vitamin D deficiency is highly prevalent in all parts of the world. Pregnant women and neonates are highly vulnerable to vitamin D deficiency. Preeclampsia is indeed associated with lower vitamin D levels and the pathophysiology of pre-eclampsia involves vitamin D and calcium metabolism through their role in immunomodulation, angiogenesis and anti-inflammatory effects. From the present study, it was observed that vitamin D and calcium levels were significantly lowered in women with pre-eclampsia as compared to those of the normotensive pregnant women. So early detection of vitamin D and calcium deficiencies may be helpful in preventing occurrence of PET and its complications.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001100 Cite this Article Read Full Article PDF

Keywords:

Pre-eclampsia; Normotensive; Vitamin D; Calcium metabolism; Immunomodulatory; Angiogenesis

References

  1. Steegers EA, von Dadelszen P, Duvekot JJ, Pi­jnenborg R. Pre-eclampsia. Lancet. 2010; 376: 631-644. PubMed: https://pubmed.ncbi.nlm.nih.gov/20598363/
  2. Nagaria T, Mitra S, Banjare SP. Single loading Low Dose MgSO4 Regimen: A simple, safe and effective alternative to Pritchard‟s Regimen for Indian Women. J Clin Diagnos Res. 2017; 11: QC06-12. PubMed: https://pubmed.ncbi.nlm.nih.gov/28969211/
  3. Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, et al. WHO Multicountry Survey on Maternal and Newborn Health Research Network. Preeclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014; 121: 14-24. PubMed: https://pubmed.ncbi.nlm.nih.gov/24641531/
  4. Magee LA, Dadelszen PV, Stones W. The FIGO Textbook of Pregnancy Hypertension; London: The Global Library of Women‟s Medicine. 2016; 1.
  5. Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014; 2: 323–333. PubMed: https://pubmed.ncbi.nlm.nih.gov/25103301/
  6. Chun LY, Guilin Q, Milan U, Wei X, Wei Z, et al. Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004; 89–90: 387–392. PubMed: https://pubmed.ncbi.nlm.nih.gov/15225806/
  7. Duley L. The global impact of preeclampsia and eclampsia. Semin Perinatol. 2009; 33: 130–137. PubMed: https://pubmed.ncbi.nlm.nih.gov/19464502/
  8. Regmi MC, Aggrawal A, Pradhan T. Loading dose versus standard regimen of magnesium sulphate in eclampsia-a randomized trial. Nepal Med Coll J. 2010; 12: 244-247. PubMed: https://pubmed.ncbi.nlm.nih.gov/21744767/
  9. Gordon R, Magee LA, Payne B, Firoz T, Sawchuck D, et al. Magnesium Sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens. J Obstet Gynaecol Can. 2014; 36: 154–163. PubMed: https://pubmed.ncbi.nlm.nih.gov/24518915/
  10. Taru G, Sonika W, Nupur G, Sarika A, Sangeeta G, et al. Correlation of Vitamin D Levels in Term Normotensive and Pre-eclamptic Patients in Labor. J Obstetr Gynecol India. 2016; 66: 154-159. PubMed: https://pubmed.ncbi.nlm.nih.gov/27298523/
  11. Sadin B, Gargari BP, Tabrizi FPF. Vitamin D Status in Preeclamptic and Non-preeclamptic Pregnant Women: A Case-Control Study in the North West of Iran. Health Promot Perspect. 2015; 5: 183-190. PubMed: https://pubmed.ncbi.nlm.nih.gov/26634196/
  12. Baker AM, Haeri S, Camargo CA Jr, Espinola JA, Stuebe AM. A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J Clin Endocrinol Metab 2010; 95: 5105-5109. PubMed: https://pubmed.ncbi.nlm.nih.gov/20719829/
  13. Abedi P, Mohaghegh Z, Afshary P, Latifi M. The relationship of serum vitamin D with pre-eclampsia in the Iranian women. Matern Child Nutr. 2014; 10: 206–212. PubMed: https://pubmed.ncbi.nlm.nih.gov/23782626/
  14. BakacakMSerin SErcan OKöstü BAvci F, et al. Comparison of Vitamin D levels in cases with preeclampsia, eclampsia and healthy pregnant women. Int J Clin Exp Med. 2015; 8: 16280-16286. PubMed: https://pubmed.ncbi.nlm.nih.gov/26629145/
  15. MohagheghZAbedi PDilgouni TNamvar FRuzafza S. The relation of preeclampsia and serum level of 25-hydroxyvitamin D in mothers and their neonates: a case control study in Iran. Horm Metab Res. 2015; 47: 284-288. PubMed: https://pubmed.ncbi.nlm.nih.gov/25611206/
  16. Mehmood S, Karim SA. Vitamin D Deficiency during Pregnancy and its Relationship with Pre-Eclampsia, Eclampsia and Gestational Hypertension. Austin J Nutr Metab. 2016; 3: 1040.
  17. Sahu M, Das V, Agarwal A, Rawat V, Saxena P, et al. Vitamin D replacement in pregnant women in rural north india: a pilot study. Eur J Clin Nutr. 2009; 63: 1157–1159. PubMed: https://pubmed.ncbi.nlm.nih.gov/19455177/
  18. Dhillon MK, Bedi GK, Kaur K. Significance of 25 hydroxy vitamin D and calcium in pregnancy induced hypertension. Int J Health Sci Res. 2017; 7: 80-85.
  19. Gogaram, Prasad H, Misha S. Comparison of maternal serum vitamin d levels in cases with preeclampsia, eclampsia and healthy pregnant women in Churu District. IJBAMR. 2018; 7: 282-288.
  20. Fischer D, Schroer A, Ludders D, Cordes T, Bücker B, et al. Metabolism of vitamin D3 in the placental tissue of normal and preeclampsia complicated pregnancies and premature births. Clin Exp Obstet Gynecol. 2007; 34: 80-84. PubMed: https://pubmed.ncbi.nlm.nih.gov/17629157/
  21. Behjat Sasan S, Zandvakili FSoufizadeh NBaybordi E. The Effects of Vitamin D Supplement on Prevention of Recurrence of Preeclampsia in Pregnant Women with a History of Preeclampsia. Obstet Gynecol Int. 2017; 8249264. PubMed: https://pubmed.ncbi.nlm.nih.gov/28912817/
  22. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin In-vest. 2002; 110: 229–238. PubMed: https://pubmed.ncbi.nlm.nih.gov/12122115/

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?